PERCEPTIVE ADVISORS LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$9.3T
Holdings
139
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (139 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | TSHATAYSHA GENE THERAPIES INC | 470,440 | $12.5B | 0.13% | |
| 102 | —TCR2 THERAPEUTICS INC | 400,000 | $12.4B | 0.13% | |
| 103 | HCATHEALTH CATALYST INC | 276,084 | $12.0B | 0.13% | |
| 104 | —BCLS ACQUISITION CORP | 1,000,000 | $11.1B | 0.12% | |
| 105 | —SC HEALTH CORP | 1,000,000 | $11.0B | 0.12% | |
| 106 | —CURIS INC | 1,250,000 | $10.2B | 0.11% | |
| 107 | MRVIMARAVAI LIFESCIENCES HLDGS I | 350,000 | $9.8B | 0.11% | |
| 108 | VRAYQVIEWRAY INC | 2,451,748 | $9.4B | 0.10% | |
| 109 | RVMDREVOLUTION MEDICINES INC | 224,224 | $8.9B | 0.10% | |
| 110 | PSTXUSDPOSEIDA THERAPEUTICS INC | 787,745 | $8.6B | 0.09% | |
| 111 | DYNDYNE THERAPEUTICS INC | 400,000 | $8.4B | 0.09% | |
| 112 | SHCSOTERA HEALTH CO | 300,000 | $8.2B | 0.09% | |
| 113 | AQSTAQUESTIVE THERAPEUTICS INC | 1,385,720 | $7.4B | 0.08% | |
| 114 | SNDXSYNDAX PHARMACEUTICALS INC | 300,000 | $6.7B | 0.07% | |
| 115 | —VINCERA PHARMA INC | 300,000 | $6.3B | 0.07% | |
| 116 | —SIGILON THERAPEUTICS INC | 125,000 | $6.0B | 0.06% | |
| 117 | —HEALTH SCIENCES ACQ CORP 2 | 450,000 | $5.8B | 0.06% | |
| 118 | —BCTG ACQUISITION CORP | 500,000 | $5.7B | 0.06% | |
| 119 | PHRPHREESIA INC | 100,000 | $5.4B | 0.06% | |
| 120 | —CONSONANCE HFW ACQUISITION C | 500,000 | $5.2B | 0.06% | |
| 121 | —DEERFIELD HEALTHCARE TECH AC | 300,000 | $4.5B | 0.05% | |
| 122 | MASS908 DEVICES INC | 77,500 | $4.4B | 0.05% | |
| 123 | AVXLANAVEX LIFE SCIENCES CORP | 780,007 | $4.2B | 0.05% | |
| 124 | PTGXPROTAGONIST THERAPEUTICS INC | 203,591 | $4.1B | 0.04% | |
| 125 | —MOTUS GI HLDGS INC | 4,210,542 | $3.9B | 0.04% | |
| 126 | —MOLECULAR TEMPLATES INC | 411,818 | $3.9B | 0.04% | |
| 127 | BNRBURNING ROCK BIOTECH LTD | 150,000 | $3.5B | 0.04% | |
| 128 | GRTXGALERA THERAPEUTICS INC | 325,000 | $3.3B | 0.04% | |
| 129 | —LIFESCI ACQUISITION II CORP | 300,000 | $3.2B | 0.03% | |
| 130 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 400,000 | $2.2B | 0.02% | |
| 131 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 139,890 | $1.7B | 0.02% | |
| 132 | RACEFERRARI N V | 6,200 | $1.4B | 0.02% | |
| 133 | —SIERRA ONCOLOGY INC | 66,655 | $1.1B | 0.01% | |
| 134 | —VINCERA PHARMA INC | 300,000 | $990.0M | 0.01% | |
| 135 | ABCLABCELLERA BIOLOGICS INC | 20,000 | $805.0M | 0.01% | |
| 136 | LEGNLEGEND BIOTECH CORP | 25,000 | $704.0M | 0.01% | |
| 137 | —SOCIAL CAPITAL HEDOSOPHIA HLD | 40,000 | $671.0M | 0.01% | |
| 138 | —DEERFIELD HEALTHCARE TECH AC | 20,000 | $312.0M | 0.00% | |
| 139 | —OUTLOOK THERAPEUTICS INC | 420,875 | $93.0M | 0.00% |
PreviousPage 2 of 2